| Heather Ferguson, EDS | |
|
315 E Dunklin St, Jefferson City, MO 65101-3128 | |
| (573) 659-3000 | |
| Not Available |
| Full Name | Heather Ferguson |
|---|---|
| Gender | Female |
| Speciality | Psychologist - School |
| Location | 315 E Dunklin St, Jefferson City, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619584257 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TS0200X | Psychologist - School | (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Heather Ferguson, EDS 315 E Dunklin St, Jefferson City, MO 65101-3128 Ph: (573) 659-3000 | Heather Ferguson, EDS 315 E Dunklin St, Jefferson City, MO 65101-3128 Ph: (573) 659-3000 |
News Archive
The issue of using or not using DES in patients with diabetes will be debated between Professor Wijns, who discourages DES and Professor Silber, who feels that they should be used.
A new study finds that a cup of green tea may protect against Alzheimer's disease and other forms of dementia. The researchers looked at the effects of a concentrated green tea extract that had been treated in the laboratory to mimic the effects of normal digestion.
Research led by Xin Zheng of Huazhong University of Science and Technology in Wuhan, China, found that about 90% of patients who recovered from COVID-19 continued to have IgG antibodies targeting the N-domain and receptor-binding domain of the spike protein. However, approximately 43% of patients showed signs of neutralizing antibody activity.
IMRIS Inc. ("IMRIS" or the "Company") today announced a new organization structure designed to position the Company to continue to meet the growing global demand for IMRIS solutions.
Trubion Pharmaceuticals, Inc. today announced that its collaboration partner, Pfizer, has initiated a Phase 2 clinical trial of SBI-087 (PF-05230895) for the treatment of rheumatoid arthritis (RA). SBI-087 is a next-generation, humanized Small Modular ImmunoPharmaceutical (SMIP(TM)) protein therapeutic directed against the CD20 antigen. SBI-087 is also being evaluated in Phase 1 clinical trials for RA and systemic lupus erythematosus (SLE).
› Verified 9 days ago
Linda Schultz, MS PSYCHOLOGIST Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1432 Southwest Blvd, Jefferson City, MO 65109 Phone: 573-632-5560 Fax: 573-632-5875 | |
Dr. Richard P Lillard, PSY.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 3405 W Truman Blvd Ste 101, Jefferson City, MO 65109 Phone: 573-864-7868 | |
Carol Rice, C.HT Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1803 Sun Valley Dr, Suite D, Jefferson City, MO 65109 Phone: 888-604-9997 | |
Richard Paul Thomlinson, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 227 Metro Dr, Jefferson City, MO 65109 Phone: 888-403-1071 Fax: 573-634-4010 | |
Wesley Clifford Thompson, PSY.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1432 Southwest Blvd, Jefferson City, MO 65109 Phone: 573-632-5560 Fax: 573-632-5875 | |
Ann Margaret Pollock, PSYD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1303 Edgewood Dr, Jefferson City, MO 65109 Phone: 573-634-5400 Fax: 573-635-9657 | |
Colin Duggan, PSYD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1432 Southwest Blvd, Jefferson City, MO 65102 Phone: 573-632-5560 |